These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8274202)
1. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient. Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202 [TBL] [Abstract][Full Text] [Related]
2. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors. Dai YF; Qiu XF; Xue JL; Liu ZD Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003 [TBL] [Abstract][Full Text] [Related]
3. Long-term expression of human factor IX cDNA in rabbits. Zhou JM; Qiu XF; Lu DR; Lu JY; Xue JL Sci China B; 1993 Nov; 36(11):1333-41. PubMed ID: 8142022 [TBL] [Abstract][Full Text] [Related]
4. Stage I clinical trial of gene therapy for hemophilia B. Lu DR; Zhou JM; Zheng B; Qiu XF; Xue JL; Wang JM; Meng PL; Han FL; Ming BH; Wang XP Sci China B; 1993 Nov; 36(11):1342-51. PubMed ID: 8142023 [TBL] [Abstract][Full Text] [Related]
5. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients. Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366 [TBL] [Abstract][Full Text] [Related]
6. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro. Lu D; Qiu X; Zheng B; Qiu X; Xue J Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200 [TBL] [Abstract][Full Text] [Related]
7. Towards gene therapy for haemophilia B using primary human keratinocytes. Gerrard AJ; Hudson DL; Brownlee GG; Watt FM Nat Genet; 1993 Feb; 3(2):180-3. PubMed ID: 8499952 [TBL] [Abstract][Full Text] [Related]
8. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793 [TBL] [Abstract][Full Text] [Related]
9. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Yao SN; Smith KJ; Kurachi K Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074 [TBL] [Abstract][Full Text] [Related]
10. [Lasting expression of hF IX mediated by myoblasts in mice]. Wang H; Yang X; Bao Y; Xue J Zhonghua Xue Ye Xue Za Zhi; 1997 Sep; 18(9):471-3. PubMed ID: 15625839 [TBL] [Abstract][Full Text] [Related]
11. Towards gene therapy for hemophilia B. Anson DS; Hock RA; Austen D; Smith KJ; Brownlee GG; Verma IM; Miller AD Mol Biol Med; 1987 Feb; 4(1):11-20. PubMed ID: 3475525 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B. Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast transplantation in rats: transduction and function of foreign genes. Neuzil D; Holzman M; Rozga J; Levine J; Moscioni AD; Demetriou AA J Surg Res; 1993 Jun; 54(6):631-7. PubMed ID: 8412074 [TBL] [Abstract][Full Text] [Related]
14. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells]. Hou J; Wang J; Min B Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060 [TBL] [Abstract][Full Text] [Related]
15. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia. High KA Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929 [TBL] [Abstract][Full Text] [Related]
16. Hybrid retroviral vector with MCK enhancers inserted in LTR for stable and specific expression of human factor IX in skeletal muscle. Wang JM; Hou J; Qiu XF; Kurachi K; Xue JL Chin Med J (Engl); 2004 Jun; 117(6):893-8. PubMed ID: 15198894 [TBL] [Abstract][Full Text] [Related]
18. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells. Wen J; Vargas AG; Ofosu FA; Hortelano G J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997 [TBL] [Abstract][Full Text] [Related]
19. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host. Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802 [TBL] [Abstract][Full Text] [Related]
20. Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes. Lozier JN; Thompson AR; Hu PC; Read M; Brinkhous KM; High KA; Curiel DT Hum Gene Ther; 1994 Mar; 5(3):313-22. PubMed ID: 8018746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]